Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metastatic disease: a drug discovery perspective.
Lehembre F, Regenass U. Lehembre F, et al. Among authors: regenass u. Semin Cancer Biol. 2012 Jun;22(3):261-71. doi: 10.1016/j.semcancer.2012.03.005. Epub 2012 Mar 30. Semin Cancer Biol. 2012. PMID: 22484560 Review.
4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.
Buchdunger E, Trinks U, Mett H, Regenass U, Müller M, Meyer T, McGlynn E, Pinna LA, Traxler P, Lydon NB. Buchdunger E, et al. Among authors: regenass u. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2334-8. doi: 10.1073/pnas.91.6.2334. Proc Natl Acad Sci U S A. 1994. PMID: 8134396 Free PMC article. Retracted.
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice.
Kim SJ, Lee HJ, Kim MS, Choi HJ, He J, Wu Q, Aldape K, Weinberg JS, Yung WK, Conrad CA, Langley RR, Lehembre F, Regenass U, Fidler IJ. Kim SJ, et al. Among authors: regenass u. Clin Cancer Res. 2015 Oct 15;21(20):4630-41. doi: 10.1158/1078-0432.CCR-14-3195. Epub 2015 Jun 23. Clin Cancer Res. 2015. PMID: 26106074 Free PMC article.
46 results